ArticleCancers2023

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.

Christoph Thomssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.